As of 2026-01-08, the Relative Valuation of Rapt Therapeutics Inc (RAPT) is (42.60) USD. This relative valuation is based on P/E multiples. With the latest stock price at 32.42 USD, the upside of Rapt Therapeutics Inc based on Relative Valuation is -231.4%.
The range of the Relative Valuation is (29.96) - (58.33) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 5.4x - 15.3x | 10.4x |
| Forward P/E multiples | 7.9x - 16.1x | 12.0x |
| Fair Price | (29.96) - (58.33) | (42.60) |
| Upside | -192.4% - -279.9% | -231.4% |
| Date | P/E |
| 2026-01-02 | -8.35 |
| 2025-12-31 | -8.88 |
| 2025-12-30 | -8.76 |
| 2025-12-29 | -9.40 |
| 2025-12-26 | -9.29 |
| 2025-12-24 | -9.40 |
| 2025-12-23 | -9.29 |
| 2025-12-22 | -9.57 |
| 2025-12-19 | -8.87 |
| 2025-12-18 | -8.93 |
| 2025-12-17 | -8.70 |
| 2025-12-16 | -8.93 |
| 2025-12-15 | -8.71 |
| 2025-12-12 | -9.65 |
| 2025-12-11 | -9.25 |
| 2025-12-10 | -9.61 |
| 2025-12-09 | -9.26 |
| 2025-12-08 | -9.17 |
| 2025-12-05 | -9.04 |
| 2025-12-04 | -9.04 |
| 2025-12-03 | -8.42 |
| 2025-12-02 | -8.48 |
| 2025-12-01 | -8.27 |
| 2025-11-28 | -8.87 |
| 2025-11-26 | -8.72 |
| 2025-11-25 | -7.86 |
| 2025-11-24 | -7.64 |
| 2025-11-21 | -7.10 |
| 2025-11-20 | -7.16 |
| 2025-11-19 | -7.43 |
| 2025-11-18 | -7.42 |
| 2025-11-17 | -7.52 |
| 2025-11-14 | -7.57 |
| 2025-11-13 | -7.29 |
| 2025-11-12 | -7.71 |
| 2025-11-11 | -7.73 |
| 2025-11-10 | -7.61 |
| 2025-11-07 | -7.57 |
| 2025-11-06 | -7.62 |
| 2025-11-05 | -7.42 |
| 2025-11-04 | -7.48 |
| 2025-11-03 | -7.70 |
| 2025-10-31 | -7.92 |
| 2025-10-30 | -7.79 |
| 2025-10-29 | -7.81 |
| 2025-10-28 | -7.90 |
| 2025-10-27 | -7.90 |
| 2025-10-24 | -7.75 |
| 2025-10-23 | -7.87 |
| 2025-10-22 | -7.87 |